Product Information

COLESEVELAM HCL 3.75 G PACKET is a generic product labeled by Cosette Pharmaceuticals, Inc., priced at $3.0453 per EA under NDC 00713093530. Its NADAC has been published 210 times since Nov 16, 2022.

FDA first approved this application on Oct 2, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

COLESEVELAM HCL 3.75 G PACKET

COLESEVELAM HYDROCHLORIDE
$3.0453per EA

Strength

3.75 g/1

NDC

00713093530

Classification

Generic

Dosage Form

FOR SUSPENSION

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

COLESEVELAM HYDROCHLORIDE

Approval Type

New Drug (NDA)

FDA Application

NDA022362

FDA Approved

10/2/2009

TE Code

AB

On Market Since

8/1/2022

Pharmacological Classes

Bile Acid Sequestrant
Bile-acid Binding Activity

Price Statistics

The NADAC for COLESEVELAM HCL 3.75 G PACKET has been published 210 times since Nov 16, 2022, and over the history we have for it it has declined 48.4%. The table below summarizes its recorded NADAC range and movement.

Current price$3.0453 per EA
All-time high$5.8990 (Nov 16, 2022)
All-time low$2.4176 (May 20, 2026)
52-week high$3.0453
52-week low$2.4176
Median price$3.1531
Average price$3.2171
Largest weekly change-24.4% (Nov 23, 2022)
Weeks tracked210
Tracking sinceNov 16, 2022

Price History

1W

+9.7%

1M

+12.6%

3M

+10.4%

6M

+26.0%

1Y

+19.9%

3Y

-21.2%

5Y

N/A

All

-48.4%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the COLESEVELAM HYDROCHLORIDE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of COLESEVELAM HCL 3.75 G PACKET?

The current National Average Drug Acquisition Cost (NADAC) for COLESEVELAM HCL 3.75 G PACKET, manufactured by Cosette Pharmaceuticals, Inc., is $3.0453 per EA (NDC 00713093530), effective Nov 18, 2026.

How has the price of COLESEVELAM HCL 3.75 G PACKET changed over time?

Over the history we have for it, the NADAC for COLESEVELAM HCL 3.75 G PACKET has declined 48.4%. It has been tracked across 210 weekly CMS publications since Nov 16, 2022.

What are the highest and lowest recorded NADAC prices for COLESEVELAM HCL 3.75 G PACKET?

Since Nov 16, 2022, the NADAC for COLESEVELAM HCL 3.75 G PACKET has ranged from a low of $2.4176 (May 20, 2026) to a high of $5.8990 (Nov 16, 2022), with a median of $3.1531 per EA.

Are there cheaper alternatives to COLESEVELAM HCL 3.75 G PACKET?

No other NADAC-published product currently shares the active ingredient and strength of COLESEVELAM HCL 3.75 G PACKET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures COLESEVELAM HCL 3.75 G PACKET?

COLESEVELAM HCL 3.75 G PACKET (NDC 00713093530) is labeled by Cosette Pharmaceuticals, Inc., and CMS classifies it as a generic product.